期刊文献+

冠心病患者血清中IgE表达水平的意义

Changes of Peripheral Blood Levels of Total Immunoglobulin E in Patients with Coronary Heart Disease
下载PDF
导出
摘要 目的:观察不同类型冠心病患者血清中IgE表达水平的意义。方法:将按美国心脏病学会/美国心脏病协会冠心病处理指南的诊断标准并经冠状动脉造影检查确诊的42例冠心病患者,分为稳定型心绞痛(SA)组20例,急性冠脉综合征(ACS)组22例;并选择冠状动脉造影正常的20例非冠心病患者作为对照组。采用ELISA法测定三组血清总IgE的水平。结果:ACS组患者血清总IgE水平为(113.55±18.61)IU/ml,明显高于对照组的(47.10±13.75)IU/ml和SA组的(51.35±13.57)IU/ml(P<0.01);SA组患者IgE水平高于对照组,但差异无统计学意义(P>0.05)。结论:随着冠心病病情加重,冠心病患者外周血中IgE表达水平升高,其可表达水平可能反映冠心病危险分层,IgE在冠心病中的作用仍有待进一步研究。 Objective :To investigate the expression level of IgE in peripheral blood of patients with different types of coronary heart disease. Methods :42 patients were diagnosed as coronary heart disease (CHD) acocording to the results of coronary angiography.42 patients were divided into two groups:stable angina(SA) group (n=20), acute coronary syndrome(ACS)group (n=22).Another 20 patients with normal coronary angiography served as control group.Serum total IgE levels was detected by ELISA method.Results :The serum total IgE levels in ACS group was significantly higher than that in SA group (113.55 ± 18.61 IU/ml vs 51.35 ± 13.57 IU/ml, P〈0.01).The serum total IgE levels in ACS group was significantly higher than that in control group(113.55 ±18.61IU/ml vs 47.10 ± 13.75 IU/ml, P〈0.01).But no significant change was seen between in control group and in SA group(P〉O.05). Conclusion:The expression level of IgE is significantly increased in patients with ACS in this study. It may reflect the risk stratification of coronary heart disease.The role of IgE remains to be further studied in coronary heart disease.
出处 《中国医学创新》 CAS 2012年第17期140-141,共2页 Medical Innovation of China
关键词 冠心病 炎症 肥大细胞 IGE Coronary artery disease Inflammation Mast cell IgE
  • 相关文献

参考文献2

二级参考文献12

  • 1丁士芳,张运,张梅,陈文强,陈玉国,李贵双,纪求尚,刘同涛,周炜.应用血管内超声技术识别冠状动脉粥样斑块[J].中华超声影像学杂志,2005,14(5):325-329. 被引量:16
  • 2LU Chao ZHAO Feng-di LI Xiao-bo YIN Lian-hua.Up-regulation of interleukin-8 expressions induced by mast cell tryptase via protease activated receptor-2 in endothelial cell line[J].Chinese Medical Journal,2005(22):1900-1906. 被引量:5
  • 3Naghavi M,Libby P,Falk E,et al.From vulnerable plaque to vulnerable patient:a call for new definitions and risk assessment strategies:Part Ⅰ.Circulation,2003,108:1664-1672.
  • 4Mintz GS,Nissen SE,Anderson WD,et al.American College of Cardiology clinical expert consensus document on standards for acquistion,measurements and reporting of intravascular ultrasound studies.J Am Coll Cardiol,2001,37:1478-1492.
  • 5Kotani J,Mintz GS,Castagna MT,et al.Intravascular ultrasound analysis of infarct-related and non-infarct-related arteries in patients who presented with an acute myocardial infarction.Circulation,2003,107:2889-2893.
  • 6Varnava AM,Mills PG,Davies MJ,et al.Relationship between coronary artery remodeling and plaque vulnerability.Circulation,2002,105:939-943.
  • 7Dollery CM,McEwan JR,Henney AM.Matrix metalloproteinases and cardiovascular disease.Circ Res,1995,77:863-868.
  • 8Higo S,Uematsu M,Yamagishi M,et al.Elevation of plasma matrix metalloproteinase-9 in the culprit coronary artery in patients with acute myocardial infarction:clinical evidence from distal protection.Circ J,2005,69:1180-1185.
  • 9Inokubo Y,Hanada H,Ishizaka H,et al.Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increasing in the coronary circulation in patients with acute coronary syndrome.Am Heart J,2001,141:211-217.
  • 10Schonbeck U,Libby P.CD40 signaling and plaque instability.Circ Res,2001,89:1092-1103.

共引文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部